Browsing: Cancer

King Faisal Specialist Hospital and Research Centre (KFSH) in Riyadh has successfully introduced a pioneering high-intensity focused ultrasound (HIFU) treatment for prostate cancer for the first time in the Kingdom. The technique improves therapeutic precision by targeting early-stage tumors confined to the prostate, preserving surrounding healthy tissue. Performed in a single session without any surgical […] The post KFSH Successfully Implements Advanced Technology to Treat Prostate Cancer appeared first on Web-Release.

On the occasion of World Cancer Day, the LAU Medical Center – Rizk Hospital organized a heartfelt event on February 4, bringing together patients, survivors, caregivers, medical professionals, and artists in a powerful celebration of resilience, compassion, and collective healing. The event opened with a welcome address by Dr. Hady Ghanem, who emphasized the medical […] The post LAU Medical Center – Rizk Hospital Honors World Cancer Day Through Stories of Courage, Care, and Hope appeared first on Web-Release.

Tawfeer Discount Store today announced the total amount of $75,000 raised to the benefit of the Lebanese Breast Cancer Foundation (LBCF), through a nationwide fundraising initiative that took place during Breast Cancer Awareness Month. This substantial donation, a testament to the collective generosity of Tawfeer customers and the contributions of participating suppliers and partners, will […] The post $75,000 DELIVERED: TAWFEER’S CAMPAIGN PROVIDES CRITICAL FUNDING FOR BREAST CANCER PATIENTS THROUGH THE LEBANESE BREAST CANCER FOUNDATION appeared first on Web-Release.

Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.

Dr. Fadlo Khuri, president of the American University of Beirut (AUB) and an internationally recognized oncologist, has been named among the 100 most influential people in oncology in 2025 by OncoDaily, the leading global media platform dedicated to cancer research, clinical practice, innovation, and oncology leadership. “The 100 Most Influential People in Oncology in 2025 […] The post AUB President Fadlo Khuri Recognized Among 100 Most Influential People in Oncology in 2025 appeared first on Web-Release.

A new genetic test developed at Mayo Clinic is redefining how clinicians diagnose and manage hereditary pancreatitis. Pancreatitis, inflammation of the pancreas, is a complex condition that can lead to chronic pain, repeated hospitalizations and serious complications including diabetes, kidney failure and pancreatic cancer. The new hereditary pancreatitis gene panel available through Mayo Clinic Laboratories […] The post Precision in the pancreas: New test transforms hereditary pancreatitis diagnosis and care appeared first on Web-Release.

This Men’s Health Month, the Dubai Chapter of the Harley Davidson motorcycle club has taken centre stage in a bold, fast-spreading initiative to raise awareness of prostate and testicular cancer across the GCC—two topics that remain challenging to address openly in the region. Launched just a week ago, the tongue-in-cheek campaign video has travelled far […] The post HARLEY DAVIDSON BIKERS ARE DRIVING CANCER AWARENESS IN MEN’S HEALTH MONTH appeared first on Web-Release.